Medisyn Technologies

Andcor recruits Board Member for Medisyn Technologies

Wayzata, MN – February 8, 2010

Andcor Companies, Inc., a pioneer in the recruiting industry with its equity-for-services fee structures and investment activities within the emerging growth market, is pleased to announce Kevin C. Lynch has joined the Board of Directors at Medisyn Technologies, Inc.

Mr. Lynch was previously Founder, CEO & President of Nistevo Corporation which he started in 1997. Kevin created a single-instance, multi-tenant delivery model combined with a subscription service payment model that was the first of its kind in enterprise software. He lead the building of the firm from a concept into a profitable concern with nearly 100 enterprise customers and over $30M in recurring revenue, ultimately selling the company to Sterling Commerce, a $800M multi-enterprise collaboration company, and AT&T company. Following the acquisition Kevin held several senior leadership positions within Sterling as Senior Vice President, most recently as the SVP of North American Sales and Filed Marketing where he managed a revenue target of $700M and a staff of over 300 professionals.

Prior to founding Nistevo, Lynch was president and co-founder of Allaire Corporation, one of the industry's leading independent e-business platform providers. With Lynch's guidance and direction, the Allaire Cold Fusion product line become a recognized leader in the market for web application development tools and was acquired by its rival Macromedia in 1999. Before joining Allaire Corp., Lynch spent ten years in technology consulting and financial services including Wolverine Trading, Terranaire, MTS Systems and Control Data Corporation.

About Medisyn Technologies

Medisyn Technologies is a unique drug and bioactive food ingrediant design and discovery company that uses proprietary technology to make drug and functional food componds discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn's Forward Engineering™ platform enables the discovery and design of novel, diverse and unexpected compounds that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to weeks and optimizing lead candidates, Medisyn's novel approach enables drug discovery customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process. For more information about Medisyn Technologies, visit the company’s website at www.medisyntech.com.

About Andcor

Andcor Companies Inc., a pioneer in the recruiting industry with its equity-for-services fee structures, is the leading resource for the assembly and development of entrepreneurial leadership teams for innovative emerging growth companies.

Founded in 1969 and headquartered in Wayzata, Minnesota, Andcor has accelerated the growth of hundreds of visionary early and expansion stage companies reach the pinnacle of their industries though customized professional and executive level search solutions.